ConductScience.org, home

Paper33979331

The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages.

de Vos AS and 3 others. PLoS Negl Trop Dis, 2021. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages. Papers, record 33979331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33979331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages.
PubMed
Journal
PLoS Negl Trop Dis
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.25
iCite
Revised in PubMed
2021-09-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiparasitic AgentsMajor topic
Communicable Disease ControlMajor topic
IvermectinMajor topic
Mass Drug AdministrationMajor topic
OnchocerciasisMajor topic
Animals
Disease Eradication
Humans
Insect Bites and Stings
Onchocerca
Simuliidae

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1675786Consequences of helminth aggregation for the dynamics of schistosomiasis.Trans R Soc Trop Med Hyg1978https://conductscience.org/library/papers/675786PubMed
225545677Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.PLoS One2014https://conductscience.org/library/papers/25545677PubMed
332173745Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring.J Infect Dis2020https://conductscience.org/library/papers/32173745PubMed
42311368ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis.Comput Methods Programs Biomed1990https://conductscience.org/library/papers/2311368PubMed
530296264The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis.PLoS Negl Trop Dis2018https://conductscience.org/library/papers/30296264PubMed
626489937Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.Parasit Vectors2015https://conductscience.org/library/papers/26489937PubMed
728114304Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.PLoS Negl Trop Dis2017https://conductscience.org/library/papers/28114304PubMed
821255577Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.Int J Parasitol2011https://conductscience.org/library/papers/21255577PubMed
926771545Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa.PLoS Negl Trop Dis2016https://conductscience.org/library/papers/26771545PubMed
103662664
Studies on the dynamics of transmission of onchocerciasis in a Sudan-savanna area of North Cameroon I. Prevailing Simulium vectors, their biting rates and age-composition at different distances from their breeding sites.
Ann Trop Med Parasitol1987https://conductscience.org/library/papers/3662664PubMed
1131805049Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs.PLoS Negl Trop Dis2019https://conductscience.org/library/papers/31805049PubMed
1225053392The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.Parasit Vectors2014https://conductscience.org/library/papers/25053392PubMed
1331723729The World Health Organization 2030 goals for onchocerciasis: Insights and perspectives from mathematical modelling: NTD Modelling Consortium Onchocerciasis Group.Gates Open Res2019https://conductscience.org/library/papers/31723729PubMed
1431269966Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.Infect Dis Poverty2019https://conductscience.org/library/papers/31269966PubMed
1527349645Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.Infect Dis Poverty2016https://conductscience.org/library/papers/27349645PubMed
1629860291How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.Clin Infect Dis2018https://conductscience.org/library/papers/29860291PubMed
1729860286Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.Clin Infect Dis2018https://conductscience.org/library/papers/29860286PubMed
1833289025Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.Clin Infect Dis2021https://conductscience.org/library/papers/33289025PubMed

Download CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42539045Modelling the impact of mass drug administration with ivermectin or moxidectin on human onchocerciasis when there is sub-optimal response of parasites to treatment.Res Sq2026https://conductscience.org/library/papers/42539045PubMed
42351083Public health impact of nuisance biting blackfly (Simulium damnosum s.l.) along the Asejire dam in Southwest, Nigeria.BMC Public Health2026https://conductscience.org/library/papers/42351083PubMed
42050461High-resolution mapping of onchocerciasis risk in Ghana using spatial machine learning models.BMC Infect Dis2026https://conductscience.org/library/papers/42050461PubMed
41746959The risk of onchocerciasis infection by human population movements between high and low transmission settings in Ghana.PLoS Negl Trop Dis2026https://conductscience.org/library/papers/41746959PubMed
41535903Modelling the effects of immigration on the re-introduction of onchocerciasis.Parasit Vectors2026https://conductscience.org/library/papers/41535903PubMed
40258021Modelling transmission thresholds and hypoendemic stability for onchocerciasis elimination.PLoS Comput Biol2025https://conductscience.org/library/papers/40258021PubMed
39599520Prevalence and Sociodemographic Risk Factors of Soil-Transmitted Helminths in Rural Communities Living in Endemic Foci of Onchocerciasis in Southern Gabon.Pathogens2024https://conductscience.org/library/papers/39599520PubMed
38662699Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis.Clin Infect Dis2024https://conductscience.org/library/papers/38662699PubMed
38321011Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy.Nat Commun2024https://conductscience.org/library/papers/38321011PubMed
37630506Status of Onchocerciasis Elimination in Gabon and Challenges: A Systematic Review.Microorganisms2023https://conductscience.org/library/papers/37630506PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33979331

GET https://conductscience.org/api/papers/v1/33979331/authors